Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Parallel-Group Study to Evaluate Pharmacokinetics of E7090 and Its Metabolite in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects

NCT04271488 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT04271488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04271488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Parallel-Group Study to Evaluate Pharmacokinetics of E7090 and Its Metabolite in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
February 27, 2020
Completion date
August 31, 2027
Enrollment
18 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic impairment